[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-371821-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-371821-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","overcoming-the-delivery-challenges-in-crisprcas9-gene-editing-for-effective-cancer-treatment-a-review-of-delivery-systems","Overcoming the Delivery Challenges in CRISPR/Cas9 Gene Editing for Effective Cancer Treatment - A Review of Delivery Systems","","Therapeutic strategies based on gene editing enable direct alteration of cellular machinery to address faulty genes involved in cancer. The CRISPR/Cas9 system is the primary gene-editing tool, and multiple Cas9 variants have been developed to handle complex disease-related genetic changes. Despite progress, clinical translation is hindered by challenges in delivering CRISPR/Cas9 into target cells both in vivo and in vitro. This review summarizes current delivery systems, weighing the advantages and limitations of extracellular vesicles and viral vectors as carriers for cancer treatment.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/overcoming-the-delivery-challenges-in-crisprcas9-gene-editing-for-effective-cancer-treatment-a-review-of-delivery-systems/371821/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/overcoming-the-delivery-challenges-in-crisprcas9-gene-editing-for-effective-cancer-treatment-a-review-of-delivery-systems/371821.png","ImageObject",300,407,{"name":42,"@type":43},"Franzy","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-22","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why is delivery a major challenge for CRISPR/Cas9 gene editing in cancer treatment?","Question",{"text":63,"@type":64},"Even with advancements in gene-editing systems, a key obstacle is transporting CRISPR/Cas to diverse target cells in vivo and in vitro so it can be clinically implemented.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What is the role of Cas9 in CRISPR/Cas9 gene editing?",{"text":68,"@type":64},"Cas9 is identified as an essential CRISPR-associated protein that enables the CRISPR system to function as a gene-editing tool for modifying genetic material.",{"name":70,"@type":61,"acceptedAnswer":71},"Which delivery vehicles does the review evaluate for cancer treatment?",{"text":72,"@type":64},"The review explores extracellular vesicles and viral vectors as vehicles for delivering the CRISPR/Cas system and discusses their benefits and drawbacks.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},371821,1790294649,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},2336478945519,"https://ap-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","Ivyspring  \nInternational Publisher  \nInternationalJournal of Medical Sciences  \n2025; 22(14): 3625-3649. doi: 10.7150/ijms.112724  \nReview  \nOvercoming the Delivery Challenges in CRISPR/Cas9 Gene Editing for Effective Cancer Treatment: A Review of Delivery Systems  \nShuting Tang1,2,\\#, Xiaoyi Chen3,\\#, Xiangmin Tong4􀀍, Lifen Zhu2􀀍  \n1. College of Materials and Engineering, Yangtze Normal University, Chongqing 408100, China.  \n2. Cancer Center, Department of Pathology, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou 310014, China.  \n3. Clinical Research Institute, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou 310014, China.  \n4. Department of Hematology, the Hangzhou First People’s Hospital, Hangzhou 310006, China.  \n\\#, These authors contributed equally to this work.  \n􀀍 Corresponding authors: Dr. Xiangmin Tong, Department of Hematology, the Hangzhou First People’s Hospital, No. 261 Huansha Road, Hangzhou 310006, China. Email: [tongxiangmin@163.com. Dr. Lifen Zhu](tongxiangmin@163.com. Dr. Lifen Zhu), Department of Pathology, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou  \nMedical College, No. 158 Shangtang Road, Hangzhou 310014, China. Email: [zhulifen@hmc.edu.cn](zhulifen@hmc.edu.cn).  \n© The author(s). This is an open access article distributed under the terms of the Creative Commons Attribution License ([https://creativecommons.org/licenses/by/4.0/](https://creativecommons.org/licenses/by/4.0/)). See [https://ivyspring.com/terms](https://ivyspring.com/terms) for full terms and conditions.  \nReceived: 2025.02.23; Accepted: 2025.06.23; Published: 2025.07.28  \nAbstract  \nTherapeutic strategies based on gene editing provide the ability to modify faulty genes contributing to the development of diseases such as cancer by directly altering the cellular machinery. The clustered regularly interspaced short palindromic repeats associated nuclease 9 (CRISPR/Cas9) system is currently the primary tool used for gene editing. Several effective Cas9 variants have already been established to address the complex genetic modifications that arise during diseases. Although gene-editing systems have made significant advancements, a primary obstacle that requires attention is the transportation of CRISPR/Cas to diverse target cells, both in vivo and in vitro, to render them suitable for clinical implementation. Various strategies can be utilized to facilitate the transportation of the CRISPR/Cas systems into mammalian cells. Herein, we reviewed contemporary research about delivery systems for gene-editing systems that interact effectively in biological systems. This review explores the benefits and drawbacks of using extracellular vesicles and viral vectors as vehicles for delivering the CRISPR/Cas system in the context of cancer treatment.  \nKeywords: CRISPR/Cas, cancer treatment, gene-editing systems, extracellular vesicles, viral vectors  \nIntroduction  \nCancer is a leading cause of mortality worldwide, giving rise to a multitude of complications across various domains. The origins of cancerous cells are associated with various genetic modifications occurring within these cells [1] . The development of cancer is significantly influenced by the presence of tumor suppressor genes and oncogenes. These two groups of genes exhibit counterbalancing effects. Tumor suppressors are known to trigger apoptosis, while oncogenes are recognized for their ability to stimulate cell proliferation. Thus, the effective utilization of anti-oncogenes and apoptotic genes can be employed  \nin the treatment of cancer. Despite the numerous advancements in screening and therapeutic techniques, the efficacy of treatment remains a formidable challenge [2] . Several therapeutic approaches have been devised, such as gene therapies and small molecules, to combat cancer by regulating the immune system or selectively targeting can","cbCaiumOTs4BFoBu","https://ap.wps.com/l/cbCaiumOTs4BFoBu","pdf",4698810,25,"English","# Introduction\n## Therapeutic rationale and cancer genetics\n## From adaptive immunity to CRISPR systems\n## CRISPR-associated proteins and Cas9","[{\"question\":\"Why is delivery a major challenge for CRISPR/Cas9 gene editing in cancer treatment?\",\"answer\":\"Even with advancements in gene-editing systems, a key obstacle is transporting CRISPR/Cas to diverse target cells in vivo and in vitro so it can be clinically implemented.\"},{\"question\":\"What is the role of Cas9 in CRISPR/Cas9 gene editing?\",\"answer\":\"Cas9 is identified as an essential CRISPR-associated protein that enables the CRISPR system to function as a gene-editing tool for modifying genetic material.\"},{\"question\":\"Which delivery vehicles does the review evaluate for cancer treatment?\",\"answer\":\"The review explores extracellular vesicles and viral vectors as vehicles for delivering the CRISPR/Cas system and discusses their benefits and drawbacks.\"}]","Overcoming the Delivery Challenges in CRISPR/Cas9 Gene Editing for Effective Cancer Treatment - A Review of Delivery Systems | PDF",1790192947,63,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/03113cdf5691414aa74543daa70d3521.webp",983,1272,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9de1814a8fa562d6cf51a6468ca5e39d.webp",982,1270,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7756b2aac0faaa6526a6c62432e3bc10.webp",981,1269,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f241e7d523abd6b7286f9dc5dd76516d.webp",980,1268]